These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 7354001)
1. Amphotericin B-induced changes in K+ content, viability, and ultrastructure of yeast-phase Histoplasma capsulatum. Arnold WN; Pringle AT; Garrison RG J Bacteriol; 1980 Jan; 141(1):350-8. PubMed ID: 7354001 [TBL] [Abstract][Full Text] [Related]
2. Histoplasma capsulatum in planktonic and biofilm forms: in vitro susceptibility to amphotericin B, itraconazole and farnesol. Brilhante RSN; de Lima RAC; Marques FJF; Silva NF; Caetano ÉP; Castelo-Branco DSCM; Bandeira TJPG; Moreira JLB; Cordeiro RA; Monteiro AJ; Camargo ZP; Sidrim JJC; Rocha MFG J Med Microbiol; 2015 Apr; 64(Pt 4):394-399. PubMed ID: 25657300 [TBL] [Abstract][Full Text] [Related]
3. Amphotericin B potentiation of rifampicin as an antifungal agent against the yeast phase of Histoplasma capsulatum. Kobbayashi GS; Medoff G; Schlessinger D; Kwan CN; Musser WE Science; 1972 Aug; 177(4050):709-10. PubMed ID: 5054147 [TBL] [Abstract][Full Text] [Related]
4. Response of yeast and mycelial phases of Histoplasma capsulatum to amphotericin B and actinomycin D. Cheung SC; Medoff G; Schlessinger D; Kobayashi GS Antimicrob Agents Chemother; 1975 Oct; 8(4):498-503. PubMed ID: 1190756 [TBL] [Abstract][Full Text] [Related]
5. Synergism of amphotericin B and 2-deoxyglucose against Histoplasma capsulatum yeasts in vitro. Berliner MD Microbios; 1975; 12(50):209-18. PubMed ID: 1160617 [TBL] [Abstract][Full Text] [Related]
6. Effects of rifamycin derivatives, alone and in combination with amphotericin B, against Histoplasma capsulatum. Kobayashi GS; Cheung SS; Schlessinger D; Medoff G Antimicrob Agents Chemother; 1974 Jan; 5(1):16-8. PubMed ID: 4840445 [TBL] [Abstract][Full Text] [Related]
7. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin. van Duin D; Casadevall A; Nosanchuk JD Antimicrob Agents Chemother; 2002 Nov; 46(11):3394-400. PubMed ID: 12384341 [TBL] [Abstract][Full Text] [Related]
8. Comparative study of the effect of thiabendazole and fungizone on Histoplasma capsulatum in macrophages. Subbaratnam S; Miller NG Sabouraudia; 1979 Sep; 17(3):331-8. PubMed ID: 394369 [TBL] [Abstract][Full Text] [Related]
9. [In vitro sensitivity of Histoplasma capsulatum var. capsulatum to amphotericin B, ketoconazole, itroconazole and fluconazole]. Andreu CM; León AM; Medina YE; Machín GM; Lancha MR; Zaragozí MT Rev Cubana Med Trop; 2003; 55(2):76-82. PubMed ID: 15849960 [TBL] [Abstract][Full Text] [Related]
10. Fungistatic and fungicidal effects of amphotericin B, ketoconazole and fluconazole (UK 49,858) against histoplasma capsulatum in vitro and in vivo. Polak A; Dixon DM Mykosen; 1987 Apr; 30(4):186-94. PubMed ID: 3035371 [No Abstract] [Full Text] [Related]
11. Comparison of the in vitro and in vivo activity of the bis-triazole derivative UK 49,858 with that of amphotericin B against Histoplasma capsulatum. Kobayashi GS; Travis S; Medoff G Antimicrob Agents Chemother; 1986 Apr; 29(4):660-2. PubMed ID: 3010852 [TBL] [Abstract][Full Text] [Related]
12. Rapid, extensive and reversible vacuolation of Schizosaccharomyces pombe induced by amphotericin B. Takeo K; Yarita K; Yoshida S; Guan HQ; Nishimura K; Miyaji M FEMS Microbiol Lett; 1993 Apr; 108(3):265-9. PubMed ID: 8514114 [TBL] [Abstract][Full Text] [Related]
13. In vitro activities of voriconazole, itraconazole, and amphotericin B against Blastomyces dermatitidis, Coccidioides immitis, and Histoplasma capsulatum. Li RK; Ciblak MA; Nordoff N; Pasarell L; Warnock DW; McGinnis MR Antimicrob Agents Chemother; 2000 Jun; 44(6):1734-6. PubMed ID: 10817743 [TBL] [Abstract][Full Text] [Related]
14. Ultrastructural changes produced by ketoconazole in the yeast-like phase of Paracoccidioides brasiliensis and Histoplasma capsulatum. Negroni de Bonvehi MB; Borgers M; Negroni R Mycopathologia; 1981 May; 74(2):113-8. PubMed ID: 6264302 [TBL] [Abstract][Full Text] [Related]
15. Ultrastructural effects of PCMS on mycelial-yeast transition in Histoplasma capsulatum. Borgia G; Tallarino A; Crowell J; Lambiase A; Reynaud L; Cicciarello S; Nappa S; Nasti G; di Gennaro G; Sardo M Boll Soc Ital Biol Sper; 1991 Dec; 67(12):1073-9. PubMed ID: 1668638 [TBL] [Abstract][Full Text] [Related]
16. Drug-induced alterations in the ultrastructural organization of Histoplasma capsulatum and Blastomyces dermatitidis. Lane JW; Garrison RG; Johnson DR Mycopathol Mycol Appl; 1972 Dec; 48(4):289-96. PubMed ID: 4119289 [No Abstract] [Full Text] [Related]
17. Effect of successful treatment with amphotericin B on Histoplasma capsulatum variety capsulatum polysaccharide antigen levels in patients with AIDS and histoplasmosis. Wheat LJ; Connolly-Stringfield P; Blair R; Connolly K; Garringer T; Katz BP; Gupta M Am J Med; 1992 Feb; 92(2):153-60. PubMed ID: 1543199 [TBL] [Abstract][Full Text] [Related]
18. [Ultrastructural study of the mycelium-yeast transition in Histoplasma capsulatum. I. Changes at 37 degrees C]. Borgia G; Tallarino A; Lambiase A; Cicciarello S; Reynaud L; Nasti G; Lobresco R; Piazza M Boll Soc Ital Biol Sper; 1990 Aug; 66(8):771-8. PubMed ID: 2291831 [TBL] [Abstract][Full Text] [Related]
19. Irreversible block of the mycelial-to-yeast phase transition of Histoplasma capsulatum. Medoff G; Sacco M; Maresca B; Schlessinger D; Painter A; Kobayashi GS; Carratu L Science; 1986 Jan; 231(4737):476-9. PubMed ID: 3001938 [TBL] [Abstract][Full Text] [Related]
20. Cysteine-independent and cysteine-requiring yeast-strains of Histoplasma capsulatum. Jacobson ES; Harrell AC Mycopathologia; 1982 Feb; 77(2):69-73. PubMed ID: 7070482 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]